Metformin treatment reduces temozolomide resistance of glioblastoma cells. [electronic resource]
Producer: 20180223Description: 78787-78803 p. digitalISSN:- 1949-2553
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Brain Neoplasms -- drug therapy
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Dacarbazine -- analogs & derivatives
- Dose-Response Relationship, Drug
- Drug Resistance, Neoplasm
- Gene Expression Regulation, Neoplastic
- Gene Regulatory Networks
- Glioblastoma -- drug therapy
- Humans
- Inhibitory Concentration 50
- Metformin -- pharmacology
- Mice, SCID
- Neoplasm Invasiveness
- SOXB1 Transcription Factors -- genetics
- Temozolomide
- Time Factors
- Transcriptome
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.